An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
PIPC will be keeping a close eye on the Senate Finance Committee’s work on health reform legislation today. The Committee is expected to discuss possible revisions to the comparative effectiveness research language already in the proposed legislation. Recently, PIPC issued a statement in support of the language in the Chairman Baucus’s bill.
PIPC Chairman Tony Coelho specifically mentioned that “Sen. Baucus’s measure creates an independent Institute governed by patients, providers, government officials and other stakeholders, and further strengthens safeguards to protect patient access to the treatment options they need. This provides a sound framework for independent, sustained, and objective research that is focused on the needs of patients.”
We’ll let you know what happens in the Committee.